mixed-primary-cultures-murine-small-intestine-intended-for-study-gut

Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells

The gut is the largest endocrine organ of the body, with hormone-secreting enteroendocrine cells located along the length of the gastrointestinal ...

Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge

G-protein-coupled receptor signalling has been suggested to be voltage dependent in a number of cell types; however, the limits of sensitivity of this potentially important phenomenon are unknown. Using the non-excitable rat megakaryocyte as a model system, we now show that P2Y receptor-evoked Ca2+ mobilization is controlled by membrane voltage in a graded and bipolar manner without evidence for a discrete threshold potential. Throughout the range of potentials studied, the peak increase in intracellular Ca2+ concentration ([Ca2+]i) in response to depolarization was always larger than the maximal reduction in [Ca2+]i following an equivalent amplitude hyperpolarization. Significant [Ca2+]i increases were observed in response to small amplitude (< 5 mV, 5 s duration) or short duration (25 ms, 135 mV) depolarizations. Individual cardiac action potential waveforms were also able to repeatedly potentiate P2Y receptor-evoked Ca2+ release and the response to trains of normally paced stimuli fused to generate prolonged [Ca2+]i increases. Furthermore, elevation of the temperature to physiological levels (36 degrees C) resulted in a more sustained depolarization-evoked Ca2+ increase compared with more transient or oscillatory responses at 20-24 degrees C. The ability of signalling via a G-protein-coupled receptor to be potentiated by action potential waveforms and small amplitude depolarizations has broad implications in excitable and non-excitable tissues.

Sensitivity limits for voltage control of P2Y receptor-evoked Ca2+ mobilization in the rat megakaryocyte.

The platelet surface membrane possesses three P2 receptors activated by extracellular adenosine nucleotides; one member of the ionotropic receptor family (P2X(1)) and two members of the G-protein-coupled receptor family (P2Y(1) and P2Y(12)). P2Y(1) and P2Y(12) receptors have firmly established roles in platelet activation during thrombosis and haemostasis, whereas the importance of the P2X(1) receptor has been more controversial. However, recent studies have demonstrated that P2X(1) receptors can generate significant functional platelet responses alone and in synergy with other receptor pathways. In addition, studies in transgenic animals indicate an important role for P2X(1) receptors in platelet activation, particularly under conditions of shear stress and thus during arterial thrombosis. This review discusses the background behind discovery of P2X(1) receptors in platelets and their precursor cell, the megakaryocyte, and how signalling via these ion channels may participate in platelet activation.

Emerging roles for P2X1 receptors in platelet activation.

The difficulty of conducting electrophysiologic recordings from the platelet has restricted investigations into the role of ion channels in thrombosis and hemostasis. We now demonstrate that the well-established synergy between P2Y(1) and P2Y(12) receptors during adenosine diphosphate (ADP)-dependent activation of the platelet alpha(IIb)beta(3) integrin also exists in murine marrow megakaryocytes, further supporting the progenitor cell as a bona fide model of platelet P2 receptor signaling. In patch clamp recordings, ADP (30 microM) stimulated a transient inward current at -70 mV, which was carried by Na(+) and Ca(2+) and was amplified by phenylarsine oxide, a potentiator of certain transient receptor potential (TRP) ion channels by phosphatidylinositol 4,5-bisphosphate depletion. This initial current decayed to a sustained phase, upon which repetitive transient inward cation currents with pre-dominantly P2X(1)-like kinetics were super-imposed. Abolishing P2X(1)-receptor activity prevented most of the repetitive currents, consistent with their activation by secreted adenosine triphosphate (ATP). Recordings in P2Y(1)-receptor-deficient megakaryocytes demonstrated an essential requirement of this receptor for activation of all ADP-evoked inward currents. However, P2Y(12) receptors, through the activation of PI3-kinase, played a synergistic role in both P2Y(1) and P2X(1)-receptor-dependent currents. Thus, direct stimulation of P2Y(1) and P2Y(12) receptors, together with autocrine P2X(1) activation, is responsible for the activation of nonselective cation currents by the platelet agonist ADP.

Interplay between P2Y(1), P2Y(12), and P2X(1) receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling.

The molecular identity of platelet Ca(2+) entry pathways is controversial. Furthermore, the extent to which Ca(2+)-permeable ion channels are functional in these tiny, anucleate cells is difficult to assess by direct electrophysiological measurements. Recent work has highlighted how the primary megakaryocyte represents a bona fide surrogate for studies of platelet signalling, including patch clamp recordings of ionic conductances. We have now screened for all known members of the transient receptor potential (TRP) family of non-selective cation channels in murine megakaryocytes following individual selection of these rare marrow cells using glass micropipettes. RT-PCR detected messages for TRPC6 and TRPC1, which have been reported in platelets and megakaryocytic cell lines, and TRPM1, TRPM2 and TRPM7, which to date have not been demonstrated in cells of megakaryocytic/platelet lineage. Electrophysiological recordings demonstrated the presence of functional TRPM7, a constitutively active cation channel sensitive to intracellular Mg(2+), and TRPM2, an ADP-ribose-dependent cation channel activated by oxidative stress. In addition, the electrophysiological and pharmacological properties of the non-selective cation channels stimulated by the physiological agonist ADP are consistent with a major role for TRPC6 in this G-protein-coupled receptor-dependent Ca(2+) influx pathway. This study defines for the first time the principal TRP channels within the primary megakaryocyte, which represent candidates for Ca(2+) influx pathways activated by a diverse range of stimuli in the platelet and megakaryocyte.

Molecular and electrophysiological characterization of transient receptor potential ion channels in the primary murine megakaryocyte.

Store-operated Ca2+ influx represents a major route by which cytosolic Ca2+ can be elevated during platelet activation, yet its molecular identity in this cell type remains highly controversial. Using quantitative RT-PCR analysis of candidate receptor-operated cation entry pathways in human platelets, we show a >30-fold higher expression of message for the recently discovered Orai1 store-operated Ca2+ channel, and also the store Ca2+ sensor STIM1, when compared to the non-selective cation channels TRPC1, TRPC6 and TRPM2. Orai1 and STIM1 gene transcripts were also detected at higher levels than TRPC1, TRPC6 and TRPM2 in primary murine megakaryocytes and human megakaryocytic cell lines. In direct electrophysiological recordings from murine megakaryocytes, Ca2+ ionophore-induced store depletion stimulated CRAC currents, which are known to require Orai1, and these overlapped with TRPC6-like currents following P2Y receptor activation. Together with recent transgenic studies, these data provide evidence for STIM1:Orai1 as a primary pathway for agonist-evoked Ca2+ influx in the platelet and megakaryocyte.

Expression profiling and electrophysiological studies suggest a major role for Orai1 in the store-operated Ca2+ influx pathway of platelets and megakaryocytes.

Glucagon-like peptide-1 (GLP-1), released from L-cells in the intestinal epithelium, plays an important role in postprandial glucose homeostasis and appetite control. Following the recent therapeutic successes of antidiabetic drugs aimed at either mimicking GLP-1 or preventing its degradation, attention is now turning towards the L-cell, and addressing whether it would be both possible and beneficial to stimulate the endogenous release of GLP-1 in vivo. Understanding the mechanisms underlying GLP-1 release from L-cells is key to this type of approach, and the use of cell line models has led to the identification of a variety of pathways that may underlie the physiological responses of L-cells to food ingestion. This review focuses on our current understanding of the signalling mechanisms that underlie L-cell nutrient responsiveness.

Nutritional regulation of glucagon-like peptide-1 secretion.

Glucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based treatments are clinically available, alternative strategies to increase endogenous GLP-1 release from L cells are hampered by our limited physiological understanding of this cell type. By generating transgenic mice with L cell-specific expression of a fluorescent protein, we studied the characteristics of primary L cells by electrophysiology, fluorescence calcium imaging, and expression analysis and show that single L cells are electrically excitable and glucose responsive. Sensitivity to tolbutamide and low-millimolar concentrations of glucose and alpha-methylglucopyranoside, assessed in single L cells and by hormone secretion from primary cultures, suggested that GLP-1 release is regulated by the activity of sodium glucose cotransporter 1 and ATP-sensitive K(+) channels, consistent with their high expression levels in purified L cells by quantitative RT-PCR. These and other pathways identified using this approach will provide exciting opportunities for future physiological and therapeutic exploration.

Glucose sensing in L cells: a primary cell study.

The neurokinin B (NKB) receptor, encoded by TACR3, is widely expressed within the central nervous system, including hypothalamic nuclei involved in regulating GnRH release. We have recently reported two mutations in transmembrane segments of the receptor and a missense mutation in NKB in patients with normosmic isolated hypogonadotropic hypogonadism (nIHH).

Hypogonadotropic hypogonadism due to a novel missense mutation in the first extracellular loop of the neurokinin B receptor.

Glucagon-like peptide-1 (GLP-1) is secreted from enteroendocrine L-cells after food intake. Increasing GLP-1 signalling either through inhibition of the GLP-1 degrading enzyme dipeptidyl-peptidase IV or injection of GLP-1-mimetics has recently been successfully introduced for the treatment of type 2 diabetes. Boosting secretion from the L-cell has so far not been exploited, due to our incomplete understanding of L-cell physiology. Elevation of cyclic adenosine monophosphate (cAMP) has been shown to be a strong stimulus for GLP-1 secretion and here we investigate the activities of adenylate cyclase (AC) and phosphodiesterase (PDE) isozymes likely to shape cAMP responses in L-cells.

Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagon-like peptide 1 secreting cells.

L-glutamine stimulates glucagon-like peptide 1 (GLP-1) secretion in human subjects and cell lines. As recent advances have enabled the study of primary GLP-1-releasing L cells, this study aimed to characterize glutamine-sensing pathways in native murine L cells. L cells were identified using transgenic mice with cell-specific expression of fluorescent markers. Cells were studied in primary colonic cultures from adult mice, or purified by flow cytometry for expression analysis. Intracellular Ca(2+) was monitored in cultures loaded with Fura2, and cAMP was studied using Förster resonance energy transfer sensors expressed in GLUTag cells. Asparagine, phenylalanine, and glutamine (10 mm) triggered GLP-1 release from primary cultures, but glutamine was the most efficacious, increasing secretion 1.9-fold with an EC(50) of 0.19 mm. Several amino acids triggered Ca(2+) changes in L cells, comparable in magnitude to that induced by glutamine. Glutamine-induced Ca(2+) responses were abolished in low Na(+) solution and attenuated in Ca(2+) free solution, suggesting a role for Na(+) dependent uptake and Ca(2+) influx. The greater effectiveness of glutamine as a secretagogue was paralleled by its ability to increase cAMP in GLUTag cells. Glutamine elevated intracellular cAMP to 36% of that produced by a maximal stimulus, whereas asparagine only increased intracellular cAMP by 24% and phenylalanine was without effect. Glutamine elevates both cytosolic Ca(2+) and cAMP in L cells, which may account for the effectiveness of glutamine as a GLP-1 secretagogue. Therapeutic agents like glutamine that target synergistic pathways in L cells might play a future role in the treatment of type 2 diabetes.

Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP.

Megakaryocytes constitute less than 1% of all marrow cells, therefore purification of these giant platelet precursor cells represents a challenge. We describe two methods to ultra-purify mature megakaryocytes from murine marrow for the purpose of extracting RNA suitable for studies of gene expression. In the first approach, unit velocity gradients are used to enrich for megakaryocytes, which are then selected by fluorescence-activated cell sorting based upon size and high surface expression of CD41. In the second method, individual megakaryocytes, identified by their distinct morphology, are extracted using glass suction pipettes. Despite the small numbers of cells that can be isolated via the latter technique, recent studies have demonstrated how this pure population can be used to detect mRNA transcripts encoding ion channels and other proteins in the native megakaryocyte.

Purification of native bone marrow megakaryocytes for studies of gene expression.

Interesse an wie der Darm Mikrobiom, den metabolischen Zustand des Hosts beeinflussen kann hat k&uuml;rzlich versch&auml;rft. Man postuliert, dass Link ist bakterielle Fermentation von &quot;unverdaulichen&quot; Pr&auml;biotika zu kurzkettigen Fetts&auml;uren (SCFAs), die wiederum die Freisetzung von Hormonen der Darm Steuern Insulin-Freisetzung und Appetit zu modulieren. Hier zeigen wir, dass SCFAs Sekretion von der Incretin Hormon Glucagon-Like Peptid (GLP)-1 von Kolon Mischkulturen in-vitro-ausl&ouml;sen. Quantitativer PCR ergab angereicherten Ausdruck des ffar2 der SCFA-Rezeptoren (grp43) und ffar3 (gpr41) in L GLP-1-sezernierende Zellen, und im Einklang mit den gemeldeten Ankopplung von GPR43 zu Gq Signalisierung Wege, SCFAs ausgel&ouml;st cytosolic Ca2 + in L-Zellen in der Prim&auml;rkultur. M&auml;usen fehlt, ffar2 oder ffar3 ausgestellt reduzierte SCFA ausgel&ouml;ste GLP-1-Sekretion in vitro und in-vivo und einer parallelen Beeintr&auml;chtigung der Glukosetoleranz. Diese Ergebnisse unterstreichen SCFAs und ihre Rezeptoren als m&ouml;gliche Ziele f&uuml;r die Behandlung von Diabetes.

Kurzkettige Fetts&auml;uren stimulieren Glucagon-Like Peptid 1 Sekretion &uuml;ber die G-Protein-gekoppelter Rezeptor FFAR2.

Interesse a come il microbioma intestinale pu&ograve; influenzare lo stato metabolico dell&#39;host ha recentemente accresciuta. Uno ha postulato link &egrave; fermentazione batterica di prebiotici &quot;indigesto&quot; di acidi grassi a catena corta (SCFAs), che a loro volta modulano il rilascio di ormoni gut controllando il rilascio di insulina e l&#39;appetito. Mostriamo qui che SCFAs innescare la secrezione di incretine ormone glucagon-like peptide -1 (GLP) da colture miste del colon in vitro. PCR quantitativa ha rivelato espressione arricchito del CSPA recettori ffar2 (grp43) e ffar3 (gpr41) nelle cellule che secernono GLP-1 L e coerente con i segnalati di accoppiamento di GPR43 a Gq signaling pathways, SCFAs generato Ca2 + citosolico in cellule in coltura primaria di L. Topi privi di ffar2 o ffar3 esposto ridotta secrezione di GLP-1 ha attivato CSPA in vitro e in vivo e un parallelo deterioramento della tolleranza al glucosio. Questi risultati evidenziano SCFAs e loro recettori come potenziali bersagli per il trattamento del diabete.

Acidi grassi a catena corta stimolare la secrezione del peptide-1 glucagone-simile tramite i recettori accoppiati a proteine G FFAR2.

&#x8FD1;&#x671F;&#x52A0;&#x5267;&#x80A0;&#x9053;&#x5FAE;&#x751F;&#x7269;&#x7EC4;&#x5982;&#x4F55;&#x5F71;&#x54CD;&#x4E3B;&#x673A;&#x7684;&#x4EE3;&#x8C22;&#x72B6;&#x6001;&#x7684;&#x5174;&#x8DA3;&#x3002;&#x5176;&#x4E2D;&#x4E00;&#x4E2A;&#x5047;&#x8BBE;&#x94FE;&#x63A5;&#x662F;&#x7EC6;&#x83CC;&#x53D1;&#x9175;&#x7684;&quot;&#x6D88;&#x5316;&quot;&#x76CA;&#x751F;&#x5143;&#x77ED;&#x94FE;&#x8102;&#x80AA;&#x9178;&#x77ED;&#x94FE;&#xFF0C;&#xFF0C;&#x8FD9;&#x53CD;&#x8FC7;&#x6765;&#x8C03;&#x5236;&#x63A7;&#x5236;&#x80F0;&#x5C9B;&#x7D20;&#x7684;&#x5206;&#x6CCC;&#x548C;&#x98DF;&#x6B32;&#x7684;&#x80C3;&#x80A0;&#x6FC0;&#x7D20;&#x7684;&#x91CA;&#x653E;&#x3002;&#x6211;&#x4EEC;&#x5728;&#x8FD9;&#x91CC;&#x5C55;&#x793A; SCFAs &#x89E6;&#x53D1; incretin &#x6FC0;&#x7D20;&#x80F0;&#x9AD8;&#x8840;&#x7CD6;&#x7D20;&#x6837;&#x80BD;-(GLP)-1 &#x6DF7;&#x5408;&#x7ED3;&#x80A0;&#x6587;&#x5316;&#x4ECE;&#x4F53;&#x5916;&#x5206;&#x6CCC;&#x3002;&#x8367;&#x5149;&#x5B9A;&#x91CF; PCR &#x63ED;&#x793A;&#x6D53;&#x7F29;&#x7684;&#x8868;&#x8FBE;&#x7684;&#x53CB;&#x534F;&#x53D7;&#x4F53; ffar2 (grp43) &#x548C; ffar3 (gpr41) GLP-1 &#x5206;&#x6CCC; L &#x7684;&#x5355;&#x5143;&#x683C;&#x4E2D;&#xFF0C;&#x5E76;&#x7B26;&#x5408;&#x62A5;&#x544A;&#x8026;&#x5408;&#x5230;&#x4FE1;&#x53F7;&#x901A;&#x8DEF;&#xFF0C;SCFAs &#x63D0;&#x51FA;&#x80DE;&#x6D46; Ca2 + L &#x7EC6;&#x80DE;&#x7684;&#x539F;&#x4EE3;&#x57F9;&#x517B;&#x7684; Gq GPR43&#x3002;&#x5C0F;&#x9F20;&#x7F3A;&#x4E4F; ffar2 &#x6216; ffar3 &#x5C55;&#x51FA;&#x51CF;&#x5C11;&#x53CB;&#x534F;&#x89E6;&#x53D1; GLP-1 &#x5206;&#x6CCC;&#x7EC6;&#x80DE;&#x4F53;&#x5916;&#x548C;&#x4F53;&#x5185;&#x548C;&#x5E73;&#x884C;&#x7684;&#x7CD6;&#x8010;&#x91CF;&#x53D7;&#x635F;&#x3002;&#x8FD9;&#x4E9B;&#x7ED3;&#x679C;&#x7A81;&#x51FA; SCFAs &#x548C;&#x5176;&#x53D7;&#x4F53;&#x4F5C;&#x4E3A;&#x6CBB;&#x7597;&#x7CD6;&#x5C3F;&#x75C5;&#x7684;&#x6F5C;&#x5728;&#x76EE;&#x6807;&#x3002;

&#x77ED;&#x94FE;&#x8102;&#x80AA;&#x9178;&#x523A;&#x6FC0;&#x80F0;&#x9AD8;&#x8840;&#x7CD6;&#x7D20;&#x6837;&#x80BD;-1 &#x901A;&#x8FC7; FFAR2 G &#x86CB;&#x767D;&#x5076;&#x8054;&#x53D7;&#x4F53;&#x7684;&#x5206;&#x6CCC;&#x3002;

Interest in how the gut microbiome can influence the metabolic state of the host has recently heightened. One postulated link is bacterial fermentation of "indigestible" prebiotics to short-chain fatty acids (SCFAs), which in turn modulate the release of gut hormones controlling insulin release and appetite. We show here that SCFAs trigger secretion of the incretin hormone glucagon-like peptide (GLP)-1 from mixed colonic cultures in vitro. Quantitative PCR revealed enriched expression of the SCFA receptors ffar2 (grp43) and ffar3 (gpr41) in GLP-1-secreting L cells, and consistent with the reported coupling of GPR43 to Gq signaling pathways, SCFAs raised cytosolic Ca2+ in L cells in primary culture. Mice lacking ffar2 or ffar3 exhibited reduced SCFA-triggered GLP-1 secretion in vitro and in vivo and a parallel impairment of glucose tolerance. These results highlight SCFAs and their receptors as potential targets for the treatment of diabetes.

Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2.

Int&eacute;r&ecirc;t dans la fa&ccedil;on dont le microbiome du tube digestif peut influencer l&#39;&eacute;tat m&eacute;tabolique de l&#39;h&ocirc;te a r&eacute;cemment accru. On postule que lien est la fermentation bact&eacute;rienne des pr&eacute;biotiques &laquo; indigeste &raquo; pour les acides gras &agrave; cha&icirc;ne courte (AGCC), qui &agrave; son tour modulent la lib&eacute;ration d&#39;hormones gut contr&ocirc;lant la lib&eacute;ration d&#39;insuline et de l&#39;app&eacute;tit. Nous montrons ici que l&#39;AGCC d&eacute;clenche la s&eacute;cr&eacute;tion des incr&eacute;tines hormone glucagon-like peptide (BPL) -1 &agrave; partir des cultures mixtes de coliques in vitro. PCR quantitative a r&eacute;v&eacute;l&eacute; enrichie d&#39;expression de l&#39;AGCC r&eacute;cepteurs ffar2 (grp43) et ffar3 (gpr41) dans les cellules s&eacute;cr&eacute;trices GLP-1 L et compatible avec le couplage de GPR43 &agrave; Gq signaling pathways, AGCC soulev&eacute;es Ca2 + cytosolique dans les cellules de L en culture primaire. Souris d&eacute;pourvues de ffar2 ou ffar3 expos&eacute;es r&eacute;duit la s&eacute;cr&eacute;tion d&eacute;clench&eacute;e CSAF GLP-1 in vitro et in vivo et une d&eacute;ficience en parall&egrave;le de la tol&eacute;rance au glucose. Ces r&eacute;sultats soulignent l&#39;AGCC et leurs r&eacute;cepteurs comme des cibles potentielles pour le traitement du diab&egrave;te.

Les acides gras &agrave; cha&icirc;ne courte stimulent la s&eacute;cr&eacute;tion de glucagon-like peptide-1 par l&#39;interm&eacute;diaire du r&eacute;cepteur coupl&eacute; aux prot&eacute;ines G FFAR2.

&#x6700;&#x8FD1;&#x306E;&#x8178;&#x5185;&#x7D30;&#x83CC;&#x30E1;&#x30BF;&#x30B2;&#x30CE;&#x30E0; &#x30DB;&#x30B9;&#x30C8;&#x306E;&#x4EE3;&#x8B1D;&#x72B6;&#x614B;&#x306B;&#x3069;&#x306E;&#x3088;&#x3046;&#x306B;&#x5F71;&#x97FF;&#x3059;&#x308B;&#x3053;&#x3068;&#x304C;&#x3067;&#x304D;&#x307E;&#x3059;&#x3078;&#x306E;&#x95A2;&#x5FC3;&#x304C;&#x9AD8;&#x307E;&#x308A;&#x307E;&#x3057;&#x305F;&#x3002;1 &#x3064;&#x306F;&#x3001;&#x30EA;&#x30F3;&#x30AF;&#x300C;&#x6D88;&#x5316;&#x300D;&#x30D7;&#x30EC;&#x30D0;&#x30A4;&#x30AA;&#x30C6;&#x30A3;&#x30AF;&#x30B9;&#x306B;&#x9806;&#x756A;&#x306B;&#x30A4;&#x30F3;&#x30B9;&#x30EA;&#x30F3;&#x5206;&#x6CCC;&#x3001;&#x98DF;&#x6B32;&#x3092;&#x5236;&#x5FA1;&#x3059;&#x308B;&#x6D88;&#x5316;&#x7BA1;&#x30DB;&#x30EB;&#x30E2;&#x30F3;&#x306E;&#x30EA;&#x30EA;&#x30FC;&#x30B9;&#x3092;&#x30E2;&#x30B8;&#x30E5;&#x30EC;&#x30FC;&#x30C8;&#x77ED;&#x9396;&#x8102;&#x80AA;&#x9178; (&#x6FC3;&#x5EA6;) &#x306E;&#x7D30;&#x83CC;&#x306E;&#x767A;&#x9175;&#x3067;&#x3059;&#x3092;&#x4EEE;&#x5B9A;&#x3057;&#x307E;&#x3057;&#x305F;&#x3002;&#x3053;&#x3053;&#x3067;, &#x30A4;&#x30F3;&#x30AF;&#x30EC;&#x30C1;&#x30F3; &#x30DB;&#x30EB;&#x30E2;&#x30F3; &#x30B0;&#x30EB;&#x30AB;&#x30B4;&#x30F3;&#x69D8;&#x30DA;&#x30D7;&#x30C1;&#x30C9; (GLP)-1 &#x6DF7;&#x4F5C;&#x5927;&#x8178;&#x304B;&#x3089;&#x4F53;&#x5916;&#x5206;&#x6CCC;&#x3092;&#x5F15;&#x304D;&#x8D77;&#x3053;&#x3059;&#x3053;&#x3068;&#x3092;&#x793A;&#x3057;&#x3066;&#x304F;&#x3060;&#x3055;&#x3044;&#x3002;&#x91CF;&#x7684;&#x306A; PCR &#x306F; SCFA &#x53D7;&#x5BB9;&#x4F53; ffar2 &#x306E;&#x8C4A;&#x304B;&#x306A;&#x8868;&#x73FE;&#x3092;&#x660E;&#x3089;&#x304B;&#x306B;&#x3057;&#x305F; (grp43) &#x3068; ffar3 (gpr41) L GLP 1 &#x3092;&#x5206;&#x6CCC;&#x3059;&#x308B;&#x7D30;&#x80DE;&#x3068;&#x306E;&#x5831;&#x544A;&#x3068;&#x77DB;&#x76FE;&#x306E;&#x30AB;&#x30C3;&#x30D7;&#x30EA;&#x30F3;&#x30B0; GPR43 &#x6FC3;&#x5EA6;&#x3092;&#x63D0;&#x8D77; L &#x7D30;&#x80DE;&#x306E;&#x521D;&#x4EE3;&#x57F9;&#x990A;&#x3067;&#x306E;&#x7D30;&#x80DE;&#x5185; ca 2 + &#x30B7;&#x30B0;&#x30CA;&#x30EB;&#x4F1D;&#x9054;&#x7D4C;&#x8DEF;&#x3001;gq &#x306E;&#x3002;Ffar2 &#x307E;&#x305F;&#x306F; ffar3 &#x306E;&#x5C55;&#x793A;&#x306B;&#x6B20;&#x3051;&#x3066;&#x3044;&#x308B;&#x30DE;&#x30A6;&#x30B9;&#x306F;&#x3001;SCFA &#x30C8;&#x30EA;&#x30AC;&#x30FC; GLP 1 &#x5206;&#x6CCC; in vitro &#x304A;&#x3088;&#x3073; in vivo &#x3068;&#x8010;&#x7CD6;&#x80FD;&#x306E;&#x4E26;&#x5217;&#x6E1B;&#x640D;&#x524A;&#x6E1B;&#x3002;&#x3053;&#x308C;&#x3089;&#x306E;&#x7D50;&#x679C;&#x304B;&#x3089;, &#x3068;&#x305D;&#x306E;&#x53D7;&#x5BB9;&#x4F53;&#x7CD6;&#x5C3F;&#x75C5;&#x306E;&#x6CBB;&#x7642;&#x306E;&#x6F5C;&#x5728;&#x7684;&#x306A;&#x30BF;&#x30FC;&#x30B2;&#x30C3;&#x30C8;&#x3068;&#x3057;&#x3066;&#x5F37;&#x8ABF;&#x8868;&#x793A;&#x3057;&#x307E;&#x3059;&#x3002;

&#x77ED;&#x9396;&#x8102;&#x80AA;&#x9178; FFAR2 &#x306E; G &#x30BF;&#x30F3;&#x30D1;&#x30AF;&#x8CEA;&#x5171;&#x5F79;&#x53D7;&#x5BB9;&#x4F53;&#x3092;&#x4ECB;&#x3057;&#x3066;&#x30B0;&#x30EB;&#x30AB;&#x30B4;&#x30F3;&#x69D8;&#x30DA;&#x30D7;&#x30C1;&#x30C9; 1 &#x5206;&#x6CCC;&#x3092;&#x523A;&#x6FC0;&#x3057;&#x307E;&#x3059;&#x3002;

&#xCC3D; &#xC790; &#xBBF8;&#xC0DD;&#xBB3C; &#xC218; &#xD638;&#xC2A4;&#xD2B8;&#xC758; &#xB300;&#xC0AC; &#xC0C1;&#xD0DC;&#xB97C; &#xC88C;&#xC6B0; &#xD558;&#xB294; &#xBC29;&#xBC95;&#xC5D0; &#xB300; &#xD55C; &#xAD00;&#xC2EC; &#xACE0;&#xC870; &#xCD5C;&#xADFC; &#xD558;&#xACE0;&#xC788;&#xB2E4;. &#xD55C; &#xC5F0;&#xACB0;&#xC774; &#xCC28;&#xB840;&#xB85C; &#xC18C;&#xD654; &#xAD00; &#xD638;&#xB974;&#xBAAC; &#xC778;&#xC290;&#xB9B0; &#xBC29;&#xCD9C; &#xBC0F; &#xC2DD;&#xC695; &#xC81C;&#xC5B4; &#xB9B4;&#xB9AC;&#xC2A4; &#xBCC0;&#xC870; &#xC9E7;&#xC740; &#xC0AC;&#xC2AC; &#xC9C0;&#xBC29;&#xC0B0;&#xC740; (SCFAs)&#xC744; &quot;&#xC18C;&#xD654;&quot; prebiotics&#xC758; &#xC138;&#xADE0;&#xC131; &#xBC1C;&#xD6A8; postulated. &#xC6B0;&#xB9AC;&#xAC00; &#xC5EC;&#xAE30; SCFAs &#xD2B8;&#xB9AC;&#xAC70;&#xB294; incretin &#xD638;&#xB974;&#xBAAC; &#xAE00; &#xB8E8;&#xCE74; &#xACE4; &#xAC19;&#xC740; &#xD3A9;&#xD0C0;&#xC774;&#xB4DC; (GLP)-1 &#xD63C;&#xD569;&#xB41C; &#xC800; &#xC2B9; &#xBB38;&#xD654;&#xC5D0;&#xC11C; &#xCCB4; &#xC678;&#xC758; &#xBD84; &#xBE44;&#xC5D0; &#xD45C;&#xC2DC;. &#xC815;&#xB7C9;&#xC801; PCR &#xACF5;&#xAC1C; SCFA &#xC218;&#xC6A9; &#xCCB4; ffar2&#xC758; &#xD48D;&#xBD80;&#xD55C; &#xC2DD; (grp43) &#xBC0F; ffar3 (gpr41) L GLP-1-&#xBD84; &#xBE44; &#xC138;&#xD3EC;, &#xADF8;&#xB9AC;&#xACE0; &#xC77C;&#xCE58;&#xB97C; &#xBCF4;&#xACE0; SCFAs &#xC81C;&#xAE30; cytosolic Ca2 + &#xAE30;&#xBCF8; &#xBB38;&#xD654;&#xC5D0;&#xC11C; L &#xC138;&#xD3EC;&#xC5D0;&#xC11C; &#xC2E0;&#xD638; &#xACBD;&#xB85C;, Gq gpr43&#xC758; &#xCEE4;&#xD50C;&#xB9C1;. Ffar2 &#xB610;&#xB294; ffar3 &#xC804;&#xC2DC; &#xBD80;&#xC871; &#xD55C; &#xC0DD;&#xC950; &#xC0DD;&#xCCB4; &#xC678; &#xBC0F; &#xC0DD;&#xCCB4; &#xC870;&#xAC74; SCFA &#xD2B8;&#xB9AC;&#xAC70; GLP-1&#xC758; &#xBD84; &#xBE44;&#xC640; &#xD3EC;&#xB3C4; &#xB2F9; &#xB0B4;&#xC131;&#xC758; &#xBCD1;&#xB82C; &#xC7A5;&#xC560; &#xAC10;&#xC18C;. &#xC774; &#xACB0;&#xACFC; &#xB2F9;&#xB1E8;&#xBCD1;&#xC758; &#xCE58;&#xB8CC;&#xC5D0; &#xB300; &#xD55C; &#xC7A0;&#xC7AC;&#xC801;&#xC778; &#xB300;&#xC0C1;&#xC73C;&#xB85C; SCFAs &#xADF8;&#xB9AC;&#xACE0; &#xADF8;&#xB4E4;&#xC758; &#xC218;&#xC6A9; &#xCCB4;&#xB97C; &#xAC15;&#xC870; &#xD45C;&#xC2DC;&#xD569;&#xB2C8;&#xB2E4;.

G-&#xB2E8;&#xBC31;&#xC9C8; &#xACB0;&#xD569; &#xC218;&#xC6A9; &#xCCB4; FFAR2 &#xD1B5;&#xD574; &#xAE00; &#xB8E8;&#xCE74; &#xACE4; &#xAC19;&#xC740; &#xD3A9; &#xD2F0; &#xB4DC;-1&#xC758; &#xBD84; &#xBE44;&#xB97C; &#xC790;&#xADF9; &#xD558;&#xB294; &#xC9E7;&#xC740; &#xC0AC;&#xC2AC; &#xC9C0;&#xBC29;&#xC0B0;.

Recientemente ha aumentado el inter&eacute;s en c&oacute;mo el microbioma intestinal puede influir en el estado metab&oacute;lico de la hostia. Uno postula enlace es la fermentaci&oacute;n bacteriana de los prebi&oacute;ticos &quot;indigesto&quot; a &aacute;cidos grasos de cadena corta (SCFAs), que a su vez modulan la liberaci&oacute;n de hormonas del intestino controla el apetito y la secreci&oacute;n de insulina. Aqu&iacute; mostramos que SCFAs desencadenan la secreci&oacute;n de la incretina hormona glucag&oacute;n p&eacute;ptido similar (GLP) -1 de cultivos mixtos de colon in vitro. PCR cuantitativa revel&oacute; la expresi&oacute;n enriquecido de la organiz&oacute; receptores ffar2 (grp43) y ffar3 (gpr41) en las c&eacute;lulas secretoras de GLP-1 L y en consonancia con los informados acoplador de GPR43 a Gq se&ntilde;alizaci&oacute;n v&iacute;as, SCFAs levantado Ca2 + citos&oacute;lico en L c&eacute;lulas en cultivo primario. Ratones que carecen de ffar2 o ffar3 exhibida reducen secreci&oacute;n activadas organiz&oacute; GLP-1 in vitro e in vivo y una debilitaci&oacute;n paralela de tolerancia a la glucosa. Estos resultados destacan SCFAs y sus receptores como blancos potenciales para el tratamiento de la diabetes.

&Aacute;cidos grasos de cadena corta estimula la secreci&oacute;n de p&eacute;ptido-1 similar al glucag&oacute;n v&iacute;a el receptor g-prote&iacute;na-juntado FFAR2.

Ingestion of a meal triggers a range of physiological responses both within and outside the gut, and results in the remote modulation of appetite and glucose homeostasis. Luminal contents are sensed by specialised chemosensitive cells scattered throughout the intestinal epithelium. These enteroendocrine and tuft cells make direct contact with the gut lumen and release a range of chemical mediators, which can either act in a paracrine fashion interacting with neighbouring cells and nerve endings or as classical circulating hormones. At the molecular level, the chemosensory machinery involves multiple and complex signalling pathways including activation of G-protein-coupled receptors and solute carrier transporters. This chapter will discuss our current knowledge of the molecular mechanisms underlying intestinal chemosensation with a particular focus on the relatively well-characterised nutrient-triggered secretion from the enteroendocrine system.

Intestinal sensing of nutrients.

Food intake is detected by the chemical senses of taste and smell and subsequently by chemosensory cells in the gastrointestinal tract that link the composition of ingested foods to feedback circuits controlling gut motility/secretion, appetite, and peripheral nutrient disposal. G-protein-coupled receptors responsive to a range of nutrients and other food components have been identified, and many are localized to intestinal chemosensory cells, eliciting hormonal and neuronal signaling to the brain and periphery. This review examines the role of G-protein-coupled receptors as signaling molecules in the gut, with a particular focus on pathways relevant to appetite and glucose homeostasis.

G-protein-coupled receptors in intestinal chemosensation.

Ingested protein is a well-recognised stimulus for glucagon-like peptide-1 (GLP-1) release from intestinal L cells. This study aimed to characterise the molecular mechanisms employed by L cells to detect oligopeptides.

Article	Year
Sensitivity limits for voltage control of P2Y receptor-evoked Ca2+ mobilization in the rat megakaryocyte. The Journal of physiology\| PubMed ID: 14645457	2004
Emerging roles for P2X1 receptors in platelet activation. Platelets\| PubMed ID: 15203715	2004
Interplay between P2Y(1), P2Y(12), and P2X(1) receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functiona... Blood\| PubMed ID: 15914557	2005
Molecular and electrophysiological characterization of transient receptor potential ion channels in the primary murine megakaryocyte. The Journal of physiology\| PubMed ID: 16857711	2006
Expression profiling and electrophysiological studies suggest a major role for Orai1 in the store-operated Ca2+ influx pathway of platelets and megakaryocytes. Platelets\| PubMed ID: 18569867	2008
Nutritional regulation of glucagon-like peptide-1 secretion. The Journal of physiology\| PubMed ID: 19001044	2009
Glucose sensing in L cells: a primary cell study. Cell metabolism\| PubMed ID: 19041768	2008
Hypogonadotropic hypogonadism due to a novel missense mutation in the first extracellular loop of the neurokinin B receptor. The Journal of clinical endocrinology and metabolism\| PubMed ID: 19755480	2009
Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagon-like peptide 1 secreting cells. British journal of pharmacology\| PubMed ID: 21054345	2011
Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP. Endocrinology\| PubMed ID: 21209017	2011
Purification of native bone marrow megakaryocytes for studies of gene expression. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 22130713	2012
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes\| PubMed ID: 22190648	2012
Intestinal sensing of nutrients. Handbook of experimental pharmacology\| PubMed ID: 22249821	2012
G-protein-coupled receptors in intestinal chemosensation. Cell metabolism\| PubMed ID: 22482725	2012
Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor. Diabetologia\| PubMed ID: 24045836	2013

Gwen Tolhurst

Biography

JoVE Journal Publications

Other Publications